WELLINGTON MANAGEMENT GROUP LLP - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 92 filers reported holding ENZO BIOCHEM INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q2 2020$2,397,000
-43.9%
1,069,890
-36.7%
0.00%0.0%
Q1 2020$4,274,000
-54.6%
1,689,361
-52.8%
0.00%
-50.0%
Q4 2019$9,407,000
-26.9%
3,576,5300.0%0.00%
-33.3%
Q3 2019$12,875,000
-1.1%
3,576,530
-7.4%
0.00%0.0%
Q2 2019$13,014,000
+11.3%
3,861,750
-9.8%
0.00%0.0%
Q1 2019$11,689,000
+1.0%
4,281,731
+2.8%
0.00%0.0%
Q4 2018$11,578,000
-27.1%
4,164,720
+8.0%
0.00%0.0%
Q3 2018$15,890,000
-34.0%
3,856,878
-16.9%
0.00%
-40.0%
Q2 2018$24,092,000
-3.6%
4,642,041
+1.8%
0.01%
-16.7%
Q1 2018$24,999,000
-28.5%
4,561,906
+6.3%
0.01%
-25.0%
Q4 2017$34,982,000
-11.7%
4,292,219
+13.5%
0.01%
-11.1%
Q3 2017$39,599,000
-8.1%
3,782,037
-3.1%
0.01%
-10.0%
Q2 2017$43,103,000
+22.7%
3,904,237
-6.9%
0.01%
+25.0%
Q1 2017$35,116,000
+19.0%
4,195,437
-1.3%
0.01%
+14.3%
Q4 2016$29,509,000
+41.3%
4,251,909
+3.6%
0.01%
+40.0%
Q3 2016$20,890,000
-12.7%
4,104,129
+2.3%
0.01%
-16.7%
Q2 2016$23,942,000
+21.3%
4,010,356
-7.5%
0.01%
+20.0%
Q1 2016$19,735,000
+4.0%
4,337,412
+2.9%
0.01%0.0%
Q4 2015$18,971,000
+31.3%
4,215,912
-7.5%
0.01%
+25.0%
Q3 2015$14,454,000
+22.8%
4,559,840
+17.4%
0.00%
+33.3%
Q2 2015$11,773,000
+24.4%
3,885,515
+21.2%
0.00%
+50.0%
Q1 2015$9,461,000
-20.6%
3,207,082
+19.6%
0.00%
-33.3%
Q4 2014$11,909,000
+326.5%
2,682,082
+394.7%
0.00%
+200.0%
Q3 2014$2,792,000542,1500.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q4 2018
NameSharesValueWeighting ↓
HARBERT FUND ADVISORS, INC. 5,620,681$20,234,00030.10%
Evermore Global Advisors, LLC 4,007,851$14,428,0003.48%
Fondren Management LP 355,000$1,278,0001.06%
CORRADO ADVISORS, LLC 196,309$707,0000.64%
MARATHON CAPITAL MANAGEMENT 193,580$697,0000.28%
KEMPNER CAPITAL MANAGEMENT INC. 95,476$344,0000.23%
EAM Investors, LLC 203,962$734,0000.19%
Ariel Investments 1,026,313$3,695,0000.05%
HighVista Strategies LLC 19,500$70,0000.05%
Paradigm Financial Partners, LLC 17,175$60,0000.03%
View complete list of ENZO BIOCHEM INC shareholders